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The NH2-terminal blocking roup of the 43-kDa peripheral membrane protein (43-kDa protein) of Torpedo post-synaptic 
membranes has been identified as myristic acid. To identify that blocking group pure 43-kDa protein was digested with 
trypsin and the blocked tryptic peptide was isolated by reverse phase HPLC. That peptide coeluted with and had the 
same amino acid composition as a synthetic peptide, myristoyl-Gly-Gln-Asp-Gln-Thr-Lys, the structure of the amino 
terminus predicted from the protein sequence deduced from a eDNA clone. The presence of myristate was confirmed 
by the precise molecular mass of the peptide, 886.5266, determined by fast atom bombardment mass spectroscopy. 
Postsynaptic membrane; Protein, 43 kDa; Myristoylation, N~-; (Torpedo) 
1. INTRODUCTION 
Nicotinic acetylcholine r ceptors (AChRs) are 
concentrated at high surface density in the post- 
synaptic membranes of vertebrate skeletal muscle 
endplates and Torpedo electrocytes (review [1]). 
The mechanisms responsible for this distribution 
are unknown but are likely to involve interactions 
between AChRs and associated peripheral pro- 
teins. In postsynaptic membranes i olated from 
Torpedo electric tissue the rotational and transla- 
tional mobilities of AChRs are severely restricted 
[2,3] with receptor mobility increased after 
removal of peripheral proteins by exposure to 
alkaline pH [4]. The predominant peripheral pro- 
tein in these membranes is a polypeptide of 43 kDa 
(43-kDa protein) present on the cytoplasmic aspect 
of the membrane [5,6] in close proximity to 
AChRs [7,8]. In the electrocyte he 43-kDa protein 
is precisely colocalized with AChRs [9] and it is 
present at equimolar amounts with AChR [10]. An 
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immunologically related eterminant is associated 
with AChRs at vertebrate neuromuscular junctions 
and in cultured muscle cells [11-14]. 
The amino acid sequence of Torpedo 43-kDa 
protein, determined by direct protein sequencing 
[15] and by eDNA cloning [16], indicates that it is 
a novel protein unrelated to known cytoskeletal 
proteins. The amino terminus of 43-kDa protein 
was resistant to Edman degradation, soneither the 
nature of the blocking group nor the sequence of 
the amino terminal tryptic peptide was determined 
chemically. That sequence was predicted from the 
eDNA sequence to be M-G-Q-D-Q-T-K [16]. If the 
initiator methionine is removed, that sequence 
contains the features matching the known 
specificity of protein N-myristoyl transferase [17]. 
N-terminal myristoylation is a relatively rare 
modification that can be important for the interac- 
tion of otherwise soluble proteins with the plasma 
membrane [18]. 
The myristoylation f 43-kDa protein in mouse 
muscle BC3H1 cells has been described [19] 
although the location of myristate within the 
primary structure was not identified. In this letter, 
we present the isolation of the blocked tryptic pep- 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 © 1989 Federation of European Biochemical Societies 65 
Volume 243, number 1 FEBS LETTERS January 1989 
tide predicted to be the amino terminus of Torpedo 
43-kDa protein through comparison of its proper- 
ties on reverse phase HPLC with a synthetic 
myristoylated N-terminal peptide. The confirma- 
tion of myristate as the blocking group on this pep- 
tide is achieved by fast atom bombardment mass 
spectroscopy. 
Mass spectra were obtained by scanning the mass range 
1000-100 at 15 s/decade. Subsequently, a multi-channel ac- 
quisition mode was used for molecular mass determination f 
the authentic material. For these experiments he mass range 
800-1000 was scanned linearly at the rate of 10 s/scan. Peak 
matching experiments were performed using a dual tipped FAB 
probe. A mixed cesium/rubidium iodide salt preparation was 
used as a source of reference ions. 
2. MATERIALS AND METHODS 
2.1. Isolation of  43-kDa protein 
Carboxamidomethyl 43-kDa protein ([14C]CAM-43K) was 
isolated as described [15] from AChR-rich membranes prepared 
from Torpedo californica electric organ. Briefy, peripheral 
proteins were extracted from membrane suspensions (4 mg pro- 
tein/ml) by exposure to pH 11 for 1 h at 25°C. Freshly prepared 
alkaline extract was reduced with dithiothreitol and then 
reacted with [~4C]iodoacetamide. Electrophoresis on 
polyacrylamide slab gels followed by electroelution was used to 
isolate [~4C]CAM-43K from other peripheral proteins. 
2.2. Peptide synthesis 
The hexapeptide (GQDQTK) proposed to represent the 
amino terminus of 43-kDa protein [16] as well as N~-myristoyl 
and N~-palmitoyl derivatives were synthesized by solid-phase 
methods [20] on an Applied Protein Technologies (Cambridge, 
MA) PSS-80 peptide synthesizer. All amino acids were coupled 
in dichloromethane/dimethylformamide s 1-hydroxylbenzo- 
triazole (HOBT) active esters that were generated in situ by 
mixing equimolar amounts of protected amino acid, 1,3-diiso- 
propylcarbodiimide, and HOBT in the coupling solvent. N"- 
Myristoylation and N~-palmitoylation were accomplished 
similarly. Deprotection and cleavage from the resin with HF 
were performed by Immuno-Dynamics Inc. (San Diego, CA). 
The peptides were purified by reverse-phase HPLC on a 2.5 × 
22 cm Vydac column using a gradient of water-acetonitrile con- 
taining 0.09070 trifluoroacetic a id (TFA). Purity of the peptides 
was confirmed by analytical HPLC, amino acid analysis, and 
microsequencing. 
2.3. Isolation of  blocked N-terminal peptide 
Tryptic digestion was performed on 160-200/~g 
[t4C]CAM-34K using the conditions described [15]. The separa- 
tion of the tryptic peptides was carried out on a Vydac C4 col- 
umn at a flow rate of 1 ml/min using a linear water-acetonitrile 
gradient [15]. Peptides whose elution positions were similar to 
that of the synthetic myristoylated peptide were repurified on a 
Vydac C~8 column using a 25-60°70 acetonitrile gradient. 
2.4. Fast atom bombardment (FAB) mass spectrometry 
FAB mass spectrometry was conducted using a ZAB-SE 
double-focusing mass spectrometer quipped with an 11-250J 
data system (VG Instruments, Danvers, MA). Both synthetic 
and authentic samples were analyzed by dispersion of an 
acetonitrile solution in -2/zl of glycerol on the FAB probe tip. 
Each mass spectrometric experiment used 100-200 pmol of 
peptide. Samples were introduced into the mass spectrometer 
and bombarded with a xenon atom beam with 8 keV energy. 
3. RESULTS 
In a previous study [15] we demonstrated the 
separation of tryptic peptides of 43-kDa protein by 
reverse-phase HPLC. To identify the appropriate 
region of the gradient in which to search for the 
predicted blocked N-terminal tryptic peptide, the 
retention properties of synthetic peptides were 
used as a reference. When placed on a C4 column 
and eluted under standard conditions, N ~- 
myristoyl-GQDQTK eluted at 37°70 acetonitrile 
while N~-palmitoyl-GQDQTK eluted 8 min later at 
41% acetonitrile (fig.l). The peptide with a free 
amino terminus was not retained on a C4 column 
(data not shown). Fig.2 shows the HPLC separa- 
tion of 4 nmol of [14C]CAM-43K after digestion 
with trypsin in comparison with the elution of N ~- 
myristoyl-GQDQTK (solid arrow, fraction 138). 
Material in the two nearest peaks, fractions 137 
and 142, were each collected and refractionated on 
a C18 reverse-phase column (fig.3). The material 
from fraction 137 was resolved into two major 
peaks, both of which had elution times well re- 
solved from that of the synthetic peptide (fig.3B). 
In contrast, only a single major peak was 
recovered from fraction 142, and that material had 
the same retention time as the synthetic 
myristoylated peptide on the C~s column (fig.3A), 
and also when rechromatographed on the Ca 
column. 
The amino acid composition of the peptide iden- 
tified in fig.3A was determined and compared to 
that of the synthetic myristoylated peptide which 
had been treated identically by passage over both 
HPLC columns. The authentic peptide contained 
the same amino acids as the synthetic peptide 
(table 1) and in the same relative ratios: two 
glutamates for every one aspartate, glycine, 
threonine and lysine residue. From a tryptic digest 
of 4.7 nmol [14C]CAM-43K,-1.7 nmol of peptide 
was recovered. Acid hydrolysis caused the 
deamidation of the glutamine residues in the syn- 
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Fig. 1. Reverse-phase separation of 1.5 nmol each of synthetic 
N~-myristoyl-GQDQTK and N~-palmitoyI-GQDQTK on a 
Vydac C4 column with 0.1°70 TFA in water as solvent A and 
0.09% TFA in acetonitrile as solvent B. The separation was 
monitored by measuring the absorbance at 214 nm. After an 
initial wash with 5 ml of 5% solvent B, peptides were eluted 
with a linear gradient from 5% to 50% in 90 rain. Flow rate was 
1.0 ml/min. 
thetic peptide and presumably in the isolated 
43-kDa peptide as well. Confirmation of glutamine 
instead of glutamate r sidues in the tryptic peptide 
might be obtained from sequence analysis. 
However, when 100 pmol of peptide were sub- 
jected to the Edman degradation, as expected no 
released amino acids were detected. Thus the 
amino terminus of this peptide, like that of intact 
43-kDa protein [15], was blocked. 
To determine unambiguously that myristic acid 
was the group blocking the amino terminus of the 
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Fig.2. Reverse-phase s paration of a digest of []4C]CAM-43K 
after cleavage with trypsin. [14C]CAM-43K (4 nmol) was 
digested as described [15], and the digest was resolved on a (24 
column under conditions identical to those in fig.l. 
Radioactivity of peptides was measured in 10/A aliquots of each 
fraction (0.5 ml). The arrow indicates the elution position of 
synthetic N~-myristoyl-GQDQTK (fig. 1). 
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Fig.3. Rechromatography on a Vydac Cls column of two 
fractions (142 in A and 137 in B) from the C4 separation of a 
tryptic digest of [t4C]CAM-43K (fig.2). The peptides were 
eluted with a linear gradient from 25% to 60% in 35 rain. The 
flow rate was 1 ml/min and fractions corresponding to A peaks 
were collected manually. The arrow indicates the elution 
position of synthetic N~-myristoyl-GQDQTK on C]s using the 
same gradient conditions. 
tryptic peptide, FAB mass spectrometry was used 
to determine precisely the mass of the isolated pep- 
tide. N~-MyristoyI-GQDQTK has a molecular 
mass of 885 and the FAB mass spectrum of the 
synthetic peptide and of the isolated tryptic peptide 
each had the [M + H] + protonated molecular signal 
at m/z 886. The molecular region of the isolated 
tryptic peptide is shown in fig.4. With the quan- 
tities of material available (typically 100-200 pmol 
Table 1 
Amino acid composition of isolated, blocked 43-kDa peptide 
and of synthetic Myr-GQDQTK after C4 and C]s columns a 
Amino acid pmoP (ratio) 
Synthetic Authentic 
Asp 140 (1) 122 (1) 
Glu 293 (2.09) 269 (2.20) 
Gly 126 (0.90) 106 (0.87) 
Thr 147 (1.05) 132 (1.08) 
Lys 137 (0.98) 126 (1.03) 
a Compositional analysis determined as described [15] by 
derivatization f acid hydrolysates with phenylisothiocyanate 
b Aliquots of 20/LI of synthetic peptide and 45/A of isolated 
tryptic peptide were hydrolyzed; background levels of other 
amino acids in samples were less than 8 pmol 
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Fig.4. FAB mass pectra of the molecular region of the N-terminal tryptic peptide isolated from Torpedo 43-kDa protein (top) and 
the CsRbl reference (bottom). Spectra re normalized tothe largest peak in the spectrum and are plotted against arrival time (in ms 
following the scan initiation). The most intense peak in the peptide spectrum is at m/z 886 corresponding to the [M + HI + protonated 
molecule. The intensities of the ~SC isotope signals associated with [M + HI ÷ are in agreement with calculated intensities. The weaker 
ions at higher masses correspond to [M +Na] ÷ at m/z 906 and [M + K] + at m/Z 924. 
per analysis) there were no structurally significant 
fragment ions visible at lower masses. The only 
other ions in the spectra at lower masses were due 
to the expected matrix ions from glycerol. To fur- 
ther confirm the composition of the isolated tryp- 
tic peptide, the protonated molecular signal was 
peak matched against he reference ion (Cs SSRbI3, 
mass 864.3415), which was obtained by bombard- 
ment of a mixed cesium/rubidium iodide salt. The 
measured mass, determined as the mean of three 
experiments, was 886.5266 which compares very 
well with the calculated mass of the protonated 
molecule of the N"-myristoyl hexapeptide 
(C40H72N9013), 886.5250. Thus the composition of 
the peptide isolated from the tryptic digest of 
43-kDa protein was established as that expected 
for N~-myristoyl-GQDQTK. 
4. DISCUSSION 
The results reported here establish that the 
43-kDa protein of Torpedo post-synaptic mem- 
branes joins the growing number of proteins 
modified by N,-myristoylation [18]. Since all the 
43-kDa protein isolated from post-synaptic mem- 
branes is resistant to Edman degradation and 
myristoyI peptide was isolated at good yield 
(-25°7o) from the tryptic digest of 43-kDa protein, 
it is likely that all the 43-kDa protein in the post- 
synaptic membrane is N~-myristoylated. In 
Torpedo electric organ 43-kDa protein is present at 
a one to one stoichiometry with AChR [10] and 
results of immunoelectronmicroscopy establish 
that its distribution is coextensive with that of 
AChR [9]. These observations raise the question 
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whether the N~-myristoylation s important for the 
interaction of the protein generally with the plasma 
membrane or specifically with the AChR. Since 
43-kDa protein can be released from the post- 
synaptic membrane by exposure to pH 11 [4], 
without modification of the NH2-terminus [15], it 
is unlikely that the myristate of 43-kDa protein 
functions imply as a hydrophobic anchor interac- 
ting with phospholipid. Capsid protein VP4 of 
picornaviruses is N~-myristoylated, and in 
poliovirus where the location of myristate has been 
determined by X-ray crystallography [21], each 
myristyl group interacts with amino acid side 
chains both in VP4, the internal protein, and in the 
surface protein VP3. Thus the myristate in 43-kDa 
protein, an internal protein, may be directly in- 
volved in interactions with AChR, a surface 
protein. 
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